Dry Eye Disease Market Projected to Reach USD 7.77 Billion by 2030, Driven by Shift Toward Prescription Drugs and Asia-Pacific Growth

Mordor Intelligence has published a new report on the Dry Eye Disease Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The dry eye disease treatment market is forecast to grow from USD 6.36 billion in 2025 to USD 7.77 billion by 2030, reflecting a steady 4.09 % CAGR over the period. This growth is backed primarily by increasing demand for prescription therapies, heightened diagnosis rates through tele‐ophthalmology, and significant expansion in Asia-Pacific. The Dry Eye Disease Market refers to the global landscape of products and therapies aimed at treating dry eye syndrome, a common condition where the eyes fail to produce enough tears or the right quality of tears to maintain adequate lubrication. This condition can lead to irritation, blurred vision, and in severe cases, damage to the ocular surface.

Report Overview: https://www.mordorintelligence.com/industry-reports/dry-eye-disease-market?utm_source=openpr


Key Market Trends

Rising Uptick in Prescription Therapies
Prescription drugs-particularly anti-inflammatory and secretagogue treatments-are quickly outpacing OTC drops. The shift reflects longer-term management strategies aimed at underlying inflammatory causes rather than only symptoms.

Evaporative Dry Eye as Primary Segment
Evaporative dry eye accounted for 53 % of the market in 2024, indicating that meibomian gland dysfunction and lipid-layer instability are major treatment drivers. Compared to aqueous-deficient cases, evaporative type remains dominant both in prevalence and treatment demand.

Growth in Advanced Dosage Forms
Their longer ocular retention time makes them appealing for patients with chronic issues.

Lifestyle and Demographic Drivers
Global rises in screen use (+0.8 %) and aging populations (+1.2 %) are major contributors to market expansion. More frequent digital device usage is creating ocular surface stress across various age groups, while the elderly remain the fastest-growing demographic for diagnosis.

Market Segmentation

The market analysis breaks down the Dry Eye Disease Market as follows:

By Product

Over‐the‐Counter (OTC) Artificial Tears & Lubricants

Prescription Drugs

Punctal Plugs

Nutraceuticals & Omega‐3 Supplements

Autologous Serum & Blood‐derived Tear Substitutes

By Disease Type

Evaporative Dry Eye

Aqueous‐deficient Dry Eye

Mixed Mechanism

By Dosage Form

Eye Drops

Ointments & Gels

Others

By Distribution Channel

Hospital Pharmacies

Independent Pharmacies & Drug Stores

Online Pharmacies & E‐commerce Portals

By Geography

North America

Europe

Asia‐Pacific

Middle East & Africa

South America

Explore Our Full Library of Healthcare Industry Research Reports

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Key Players

The market is fragmented, with a mix of global pharmaceutical giants and specialized ophthalmic firms. Among the top companies are:

Santen Pharmaceuticals
A Japanese-based specialist in ophthalmology, Santen is recognized for its strong position in dry eye treatments, particularly in its home market of Japan and across Asia-Pacific.

OASIS Medical
Known for its artificial tear products, OASIS Medical holds a notable presence in both OTC and clinical markets for dry eye management.

Alcon Inc.
A global leader in eye-care, Alcon leverages a broad portfolio-from lubricants to prescription therapies-and has integrated pipelines via acquisitions, such as that of Aerie.

AbbVie Inc. (Allergan)
A key pharmaceutical contender in the field, AbbVie (which includes Allergan) contributes prescription therapies and holds significant market share in dry eye solutions.

Bausch Health (Bausch + Lomb)
Through its Bausch + Lomb subsidiary, this company offers a broad range of products including lubricants, prescription drops, and nutritional options targeting dry eye

For More Information Visit: https://www.mordorintelligence.com/industry-reports/dry-eye-disease-market/companies?utm_source=openpr

Conclusion

Driven by shifts in therapy preferences, innovative dosage forms, and global demographic trends, the Dry Eye Disease Market is set for steady but consistent growth between 2025 and 2030. Prescription-based, disease-modifying drugs are gaining ground, supported by technological innovations and e-commerce reach. Evaporative dry eye remains a dominant challenge, especially in regions with high screen usage and aging populations. North America remains the top market today, though Asia-Pacific offers strong future potential.

As awareness rises and treatment options diversify, key players across pharmaceuticals and diagnostics stand to benefit-particularly those focusing on advanced therapies, digital reach, and patient-first formulations.

Industry Related Reports

Bionic Eyes Market : The Bionic Eyes Market report segments the industry into By Type (External Eye, Implanted Eye), By Technology (Mechanical, Electronic), By Indication (Vision Loss and Impairment, Dry Age-related Macular Degeneration (Dry AMD), Others), By End User (Hospitals, Ophthalmic Clinics, Others), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).

Get More insights: https://www.mordorintelligence.com/industry-reports/bionic-eyes-market?utm_source=openpr

UAE Ophthalmic Devices Market: The UAE Ophthalmic Diagnostic Equipment Market report segments the industry into By Devices (Surgical Devices [Glaucoma Drainage Devices, Glaucoma Stents and Implants, Intraocular Lenses, Lasers, and more], Diagnostic and Monitoring Devices [Autorefractors and Keratometers, Corneal Topography Systems, Ophthalmic Ultrasound Imaging Systems, and more], Vision Correction Devices [Spectacles, and more]).

Get More insights: https://www.mordorintelligence.com/industry-reports/uae-ophthalmic-devices-market?utm_source=openpr

Europe Ophthalmology Drug and Device Market: The report covers European Ophthalmology Pharmaceutical Companies, and the market is segmented by Product (Devices, and Drugs), Disease (Glaucoma, Cataract, Age-related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Other Diseases), and Geography (Germany, UK, France, Italy, Spain, and the Rest of Europe). The report offers the value (in USD Million) for the above segments.


Get More insights: https://www.mordorintelligence.com/industry-reports/european-opthalmic-drugs-devices-market-industry?utm_source=openpr


About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.